Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
PAVM — PAVmed Inc.
NASDAQ
FULL STOCK PAGE →

Q4 2025 Earnings Call Summary

MAR 30, 2026
REVENUE
$52000 +940.0%
NET MARGIN
-2428.8% +105231.2 PTS
EPS
-$2.37 +72.8%
FREE CASH FLOW
-$1.6M -74.1%

No summary has been written for this call yet.